Caption Management, LLC Revolution Medicines, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $929,600 - $1.17 Million	-35,000 Reduced 70.0%	15,000 $483,000
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $561,510 - $1.04 Million	30,600 Added 157.73%	50,000 $1.43 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $692,175 - $963,874	-27,500 Reduced 58.64%	19,400 $536,000
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $951,132 - $1.27 Million	46,900 New	46,900 $1.25 Million
Q4 2021 Feb 11, 2022	SELL	$24.35 - $33.7 $711,020 - $984,040	-29,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.95 - $33.41 $699,340 - $975,571	29,200 New	29,200 $803,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.